ClinVar Miner

Submissions for variant NM_000038.6(APC):c.5800C>T (p.Pro1934Ser)

dbSNP: rs1554087001
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV003742746 SCV000647609 uncertain significance Familial adenomatous polyposis 1 2023-05-22 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt APC protein function. ClinVar contains an entry for this variant (Variation ID: 470021). This variant has not been reported in the literature in individuals affected with APC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1934 of the APC protein (p.Pro1934Ser).
Color Diagnostics, LLC DBA Color Health RCV001185484 SCV001351699 uncertain significance Hereditary cancer-predisposing syndrome 2019-02-25 criteria provided, single submitter clinical testing
Ambry Genetics RCV001185484 SCV002653410 uncertain significance Hereditary cancer-predisposing syndrome 2022-01-21 criteria provided, single submitter clinical testing The p.P1934S variant (also known as c.5800C>T), located in coding exon 15 of the APC gene, results from a C to T substitution at nucleotide position 5800. The proline at codon 1934 is replaced by serine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.